Adrenergic control of melanocytes.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001001:Anura; D002110:Caffeine / Q000494:pharmacology; D002395:Catecholamines / Q000502:physiology*; D002856:Chromatophores / Q000187:drug effects / Q000502:physiology*; D000242:Cyclic AMP / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008543:Melanins; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology; D008544:Melanocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D010656:Phenylephrine / Q000494:pharmacology; D010858:Pigmentation / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D012867:Skin / Q000187:drug effects; D014043:Tolazoline / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D002395:Catecholamines; D008543:Melanins; D010656:Phenylephrine; D002110:Caffeine; D000324:Adrenocorticotropic Hormone; D009074:Melanocyte-Stimulating Hormones; D011433:Propranolol; D014043:Tolazoline; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D004837:Epinephrine